Letter: Therapeutic Targeting of PPARs in PBC-Additional Considerations. Authors' Reply.
Saved in:
| Title: | Letter: Therapeutic Targeting of PPARs in PBC-Additional Considerations. Authors' Reply. |
|---|---|
| Authors: | Schattenberg JM; Department of Internal Medicine 2, Saarland University Homburg, Homburg, Germany., Banales JM; Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute-Donostia University Hospital, University of the Basque Country (UPV/EHU), Ikerbasque, CIBERehd, San Sebastian, Spain.; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain., Trivedi P; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, UK., Hirschfield G; Toronto General Hospital, University Health Network (UHN), Toronto, ON, Canada and Division of Gastroenterology and Hepatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2026 Jul; Vol. 64 (2), pp. 293-294. Date of Electronic Publication: 2026 Jun 03. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
